Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

ECHA update

10 May 2019 07:00

RNS Number : 5861Y
Symphony Environmental Tech. PLC
10 May 2019
 

 

 

10 May 2019

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

("Symphony", the "Company" or "the Group")

 

Market Update

EU ABANDONS SCIENTIFIC INVESTIGATION INTO OXO-PLASTICS

 

Symphony Environmental Technologies Plc (AIM: SYM), a global specialist in products and technologies that "make plastic smarter" is pleased to advise, further to its statement on 15 March 2019, that the European Chemicals Agency (ECHA) has been instructed by the European Commission to close the oxo-degradable plastics restriction process which commenced in December 2017 because the Commission thought that those plastics created microplastics. This still leaves the EU Single-use Plastics Directive in draft, but it is now clear that there is no scientific dossier published by ECHA to support any restriction on such plastics in Europe.

Michael Laurier, Symphony's CEO said "Microplastics are created by the disintegration of ordinary plastics, and they are very persistent. Oxo-biodegradable plastics like d2w are necessary, because they are for the time being the only way to prevent the accumulation of plastics and microplastics in the open environment. They do this by degrading much more quickly than ordinary plastic so that they can then be properly biodegraded and recycled back into nature by bacteria and fungi, and will not accumulate as a problem for future generations."

Symphony's d2w oxo-biodegradable technology is used all over the world and has been proved to properly biodegrade, to be recyclable, and to have a proven environmental benefit. The technology has been made mandatory in Saudi Arabia, the UAE and Pakistan after extensive due diligence, and their example is being followed by other countries.

Enquiries

Symphony Environmental Technologies Plc

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

www.symphonyenvironmental.com

Cantor Fitzgerald Europe

David Foreman, Richard Salmond, Michael Boot (Corporate Finance)

Tel: +44 (0) 20 7894 7000

Caspar Shand Kydd, Gregor Paterson (Sales)

NOTES TO EDITORS:

About Symphony Environmental Technologies plc

Symphony was founded in 1995 and was admitted to the AIM market of the London Stock Exchange in 2001. The company has developed and continues to develop, controlled-life plastic technology which helps tackle the problem of microplastics by turning ordinary plastic at the end of its service-life into biodegradable materials. It is then no longer a plastic and can be bioassimilated in the open environment in a similar way to a leaf. The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products around the world. The science of oxo-biodegradation has recently been reviewed by a former judge of the High Court in England. See http://www.biodeg.org/2018/11/06/uk-judge-find-the-case-for-oxo-biodegradable-plastic-proven/ 

Symphony licences the manufacture of its products in Europe, Asia, and the USA.

In addition, Symphony has developed a range of additives, concentrates and master-batches marketed under its d2p® brand, which can be incorporated in a wide variety of plastic and non-plastic products so as to give them protection against many different types of bacteria, fungi, algae, moulds, and insects, and against fire. d2p products also include odour, moisture and ethylene adsorbers as well as other types of food-preserving technologies. We have also launched d2p anti-microbial household gloves and toothbrushes, and are developing a range of other d2p finished products for retail sale.

Symphony has also developed the d2Detector®, a portable device which analyses plastics and detects counterfeit products. This is useful to government officials tasked with enforcing legislation, and Symphony's d2t tagging and tracer technology is available for further security.

Symphony has a diverse and growing customer-base and has established itself as an international business with 74 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is accredited to ISO9001 and ISO14001.

Symphony is a member of The Oxo-biodegradable Plastics Association (OPA) and actively participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO). D2w has been awarded an Eco-label by the Brazilian Standards Authority.

Further information on the Symphony Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv See also Symphony on Instagram. A Symphony App is available for downloading to smartphones. For oxo-biodegradable plastic generally see the OPA website at www.biodeg.org 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUKAWRKAAVRAR
Date   Source Headline
24th Jun 201111:29 amRNSResult of Annual General Meeting
24th Jun 201110:00 amRNSAGM Statement
23rd Jun 20117:00 amRNSd2w Update
22nd Jun 201111:48 amRNSNotification of Major Interest in Shares
1st Jun 20117:00 amRNSNotice of AGM
20th May 20117:00 amRNSExercise of Options and Issue of Equity
16th May 20117:00 amRNSIssue of Equity and Directors Dealings
27th Apr 20114:28 pmRNSHolding(s) in Company
21st Apr 20117:00 amRNSUS Distribution Agreement commences
11th Apr 20117:00 amRNSExercise of Options
5th Apr 20117:00 amRNSFinal Results
31st Mar 20117:00 amRNSChange of Adviser
28th Feb 20117:00 amRNSTotal Voting Rights
23rd Feb 20117:00 amRNSUSA Distribution Agreement and major PR campaign
9th Feb 20113:45 pmRNSExercise of Options and Issue of Equity
31st Jan 20113:30 pmRNSExercise of Options and Issue of Equity
14th Jan 20111:45 pmRNSHolding(s) in Company
11th Jan 20113:00 pmRNSHolding(s) in Company
1st Dec 20101:15 pmRNSHolding(s) in Company
29th Oct 20108:50 amRNSTotal Voting Rights
12th Oct 20102:00 pmRNSExercise of warrants
9th Sep 201012:45 pmRNSDirector/PDMR Shareholding
8th Sep 20103:30 pmRNSGrant of share options
6th Sep 20107:00 amRNSHalf Yearly Report
3rd Sep 201012:45 pmRNSExercise of warrants
6th Aug 201012:20 pmRNSInterim Results date and new technology contract
30th Jun 20103:50 pmRNSCompletion of reorganisation
21st Jun 201010:50 amRNSDirector/PDMR Shareholding
14th Jun 20107:00 amRNSDirector's dealings
28th May 20102:40 pmRNSTotal Voting Rights
28th May 201010:40 amRNSResult of AGM
17th May 201012:00 pmRNSDirectorate Change
11th May 20105:20 pmRNSIssue of Equity
5th May 20107:00 amRNSLeading Hotel Group to Use d2w Technology
29th Apr 20107:00 amRNSNotice of AGM
1st Apr 201012:26 pmRNSShare Options
30th Mar 201010:30 amRNSDirector/PDMR Shareholding
30th Mar 20107:00 amRNSFinal Results
26th Mar 201012:50 pmRNSChange of Registered Office
8th Mar 20108:00 amRNSNotice of Results
25th Jan 201011:30 amRNSShare Options
7th Jan 20107:00 amRNSBNY Mellon Level 1 ADR Programme
16th Dec 20097:00 amRNSDistribution Agreement
20th Nov 200912:00 pmRNSSupply Agreement with Superfos
30th Oct 20093:02 pmRNSTotal Voting Rights
2nd Oct 20092:33 pmRNSHolding(s) in Company
25th Sep 200912:23 pmRNSIssue of Equity
10th Sep 20097:00 amRNSInterim Results
14th Aug 20097:00 amRNSChange of Name of Nominated Adviser and Broker
5th Aug 20091:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.